복약 준수 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 유형별, 약제별, 지역별 세분화 및 경쟁 구도(2020-2030년)

The Global Medication Adherence Market, valued at USD 2.66 Billion in 2024, is projected to experience a CAGR of 5.30% to reach USD 3.63 Billion by 2030. Medication adherence solutions encompass technologies and services designed to ensure patients consistently follow prescribed medication regimens concerning dosage, timing, and frequency. This market's growth is primarily driven by the escalating global prevalence of chronic diseases, such as diabetes and cardiovascular conditions, the expanding geriatric population requiring long-term treatment, and continuous advancements in healthcare technology, including widespread smartphone adoption for health management. Further impetus comes from a growing emphasis on patient-centric care models and increasing collaborations across the healthcare ecosystem.

Key Market Drivers

The escalating prevalence of chronic diseases represents a primary driver for the global medication adherence market. Conditions such as diabetes, cardiovascular disease, and respiratory ailments necessitate long-term medication regimens, often complex, for effective management and prevention of severe complications. The sheer scale of this challenge underscores the critical need for solutions that support consistent patient adherence. According to the International Diabetes Federation, in 2024, 589 million adults aged 20 to 79 years are living with diabetes, a condition demanding rigorous medication adherence to mitigate serious health consequences and healthcare burdens.

Key Market Challenges

The high cost of pharmaceuticals and patient cost-sharing presents a significant challenge to the growth of the Global Medication Adherence Market. When medication expenses become prohibitive, patients frequently resort to strategies such as reducing prescribed dosages, delaying refills, or entirely discontinuing essential treatments. This financial impediment directly undermines the utility and adoption of medication adherence solutions, as patients prioritize immediate cost reduction over long-term health management facilitated by adherence technologies.

Key Market Trends

The integration of Artificial Intelligence in adherence monitoring is fundamentally transforming how patients engage with their prescribed treatments. AI-powered platforms leverage advanced algorithms to analyze patient behavior, identify non-adherence patterns, and deliver highly personalized interventions, moving beyond generic reminders. These intelligent systems facilitate predictive analytics to pinpoint individuals at high risk of non-adherence, enabling proactive support. According to American Medical Association survey data, 66% of physicians reported using AI in their practices in 2024, a significant increase from 38% in 2023, demonstrating growing adoption of AI in clinical settings. This technological shift enhances the effectiveness of medication management by tailoring support to individual patient needs.

Key Market Players

• AdhereTech Inc.
• Cardinal Health Inc.
• Everwell Technology Ltd
• InhandPlus Inc.
• Johnson & Johnson
• Koninklijke Philips N.V.
• McKesson Corporation
• MedAdvisor International Pty Ltd
• Medminder Systems, Inc.
• Omnicell, Inc.

Report Scope:

In this report, the Global Medication Adherence Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Medication Adherence Market, By Type:

• Hardware Centric
• Software Centric

Medication Adherence Market, By Medication:

• Cardiovascular
• Central Nervous System
• Diabetes
• Oncology
• Gastrointestinal
• Musculoskeletal
• Others

Medication Adherence Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Medication Adherence Market.

Available Customizations:

Global Medication Adherence Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Medication Adherence Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Hardware Centric, Software Centric)
  • 5.2.2. By Medication (Cardiovascular, Central Nervous System, Diabetes, Oncology, Gastrointestinal, Musculoskeletal, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Medication Adherence Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Medication
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Medication Adherence Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Medication
  • 6.3.2. Canada Medication Adherence Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Medication
  • 6.3.3. Mexico Medication Adherence Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Medication

7. Europe Medication Adherence Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Medication
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Medication Adherence Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Medication
  • 7.3.2. France Medication Adherence Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Medication
  • 7.3.3. United Kingdom Medication Adherence Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Medication
  • 7.3.4. Italy Medication Adherence Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Medication
  • 7.3.5. Spain Medication Adherence Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Medication

8. Asia Pacific Medication Adherence Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Medication
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Medication Adherence Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Medication
  • 8.3.2. India Medication Adherence Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Medication
  • 8.3.3. Japan Medication Adherence Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Medication
  • 8.3.4. South Korea Medication Adherence Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Medication
  • 8.3.5. Australia Medication Adherence Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Medication

9. Middle East & Africa Medication Adherence Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Medication
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Medication Adherence Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Medication
  • 9.3.2. UAE Medication Adherence Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Medication
  • 9.3.3. South Africa Medication Adherence Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Medication

10. South America Medication Adherence Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Medication
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Medication Adherence Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Medication
  • 10.3.2. Colombia Medication Adherence Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Medication
  • 10.3.3. Argentina Medication Adherence Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Medication

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Medication Adherence Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. AdhereTech Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Cardinal Health Inc.
• 15.3. Everwell Technology Ltd
• 15.4. InhandPlus Inc.
• 15.5. Johnson & Johnson
• 15.6. Koninklijke Philips N.V.
• 15.7. McKesson Corporation
• 15.8. MedAdvisor International Pty Ltd
• 15.9. Medminder Systems, Inc.
• 15.10. Omnicell, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer